Assignee
REVIVICOR INC
US8 patents
Top patents by PatentIndex Score
US7795493B2Sep 14, 2010
Porcine animals lacking any expression of functional alpha 1, 3 galactosyltransferase
REVIVICOR INC34 citations85
US10130737B2Nov 20, 2018
Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
REVIVICOR INC10 citations79
US10149461B2Dec 11, 2018
Immunocompromised ungulates
REVIVICOR INC9 citations74
US11085054B2Aug 10, 2021
Ungulates with genetically modified immune systems
REVIVICOR INC0 citations60
US12569592B2Mar 10, 2026
Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
REVIVICOR INC0 citations59
US10912863B2Feb 9, 2021
Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
REVIVICOR INC0 citations58
US10383317B2Aug 20, 2019
Multi-transgenic pigs for diabetes treatment
REVIVICOR INC1 citations57
US11172658B2Nov 16, 2021
Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferase
REVIVICOR INC1 citations55